A novel intracellular isoform of VEGFR-1 activates Src and promotes cell invasion in MDA-MB-231 breast cancer cells.
about
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in CancerA randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.Tumour cells expressing single VEGF isoforms display distinct growth, survival and migration characteristicsPhosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors.Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma.Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancerProtein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonistTumor microenvironment and breast cancer progression: a complex scenario.Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity.LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET.A truncated-Flt1 isoform of breast cancer cells is upregulated by Notch and downregulated by retinoic acid.New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.Integrative meta-modeling identifies endocytic vesicles, late endosome and the nucleus as the cellular compartments primarily directing RTK signaling.All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action.
P2860
Q27001635-BAE25B43-C77E-4026-85DE-8A210636B8B6Q33415009-2CA02401-65E6-42DE-85EB-79B78581ABDDQ34041280-5CE9C8B8-3707-48DD-A80F-E3BBE99D98C5Q34334516-BA54FE36-DEC1-4663-8B4F-1554A163DCA3Q34443645-A950D622-4536-40AA-A05A-57A2AE955286Q37083038-71D21B41-0BE2-480D-85EB-9A47FDB065BDQ37230805-C5B6E091-9CEF-46D1-A6FE-960401749317Q37984168-FE756460-BA9E-409D-A524-657CA00C7C71Q38673511-81F7FEDA-7CB7-423B-9AA2-8490E0960D5EQ38913406-80E822AF-6AC7-4E7F-BA1C-D2A4C3F1379AQ39117307-7F16387B-B954-4E13-84F9-2AA5E71C80C6Q39501588-EED3132D-1F2F-4235-A036-D4A56D8979B5Q40463360-E406F087-3187-46DD-8B7C-AFF5748A2B68Q53820295-C1CFC670-D63C-402C-A2C2-69C994B88382
P2860
A novel intracellular isoform of VEGFR-1 activates Src and promotes cell invasion in MDA-MB-231 breast cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A novel intracellular isoform ...... DA-MB-231 breast cancer cells.
@ast
A novel intracellular isoform ...... DA-MB-231 breast cancer cells.
@en
type
label
A novel intracellular isoform ...... DA-MB-231 breast cancer cells.
@ast
A novel intracellular isoform ...... DA-MB-231 breast cancer cells.
@en
prefLabel
A novel intracellular isoform ...... DA-MB-231 breast cancer cells.
@ast
A novel intracellular isoform ...... DA-MB-231 breast cancer cells.
@en
P2093
P2860
P356
P1476
A novel intracellular isoform ...... DA-MB-231 breast cancer cells.
@en
P2093
Belén Mezquita
Cristóbal Mezquita
Jovita Mezquita
Montserrat Pau
P2860
P304
P356
10.1002/JCB.22584
P577
2010-06-01T00:00:00Z